Pharmaceutical

SK bioscience to expand vaccine manufacturing plant in South Korea

SK bioscience has broken ground on a significant expansion of its vaccine manufacturing facility, L HOUSE, in South Korea.

Mar 9, 2024 - 18:00
SK bioscience to expand vaccine manufacturing plant in South Korea
SK bioscience has broken ground on a significant expansion of its vaccine manufacturing facility, L HOUSE, in South Korea.
Read the original article

Tags:

Previous Article

Oligonucleotides: Overcoming sustainability challenges with manufacturing

Next Article

Johnson & Johnson acquires Ambrx Biopharma for $2bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

What will it take to end health care worker burnout?

What will it take to end health care worker burnout?

Oct 26, 2023

STAT+: PBMs were the target of House hearing, but pharma wasn’t spared criticism

STAT+: PBMs were the target of House hearing, but pharm...

Sep 20, 2023

STAT+: Do GLP-1s have a future treating alcoholism?

STAT+: Do GLP-1s have a future treating alcoholism?

Dec 3, 2023